Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia
Clinical trial NCT00085891 · COMPLETED
Trial details
- NCT number
- NCT00085891
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 535
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.